Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
3.200
0.00 (0.00%)
At close: Aug 22, 2025, 4:00 PM
3.190
-0.010 (-0.31%)
After-hours: Aug 22, 2025, 7:58 PM EDT
Tivic Health Systems Revenue
Tivic Health Systems had revenue of $86.00K in the quarter ending June 30, 2025, a decrease of -38.57%. This brings the company's revenue in the last twelve months to $462.00K, down -58.49% year-over-year. In the year 2024, Tivic Health Systems had annual revenue of $780.00K, down -33.67%.
Revenue (ttm)
$462.00K
Revenue Growth
-58.49%
P/S Ratio
3.99
Revenue / Employee
$66,000
Employees
7
Market Cap
3.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 780.00K | -396.00K | -33.67% |
Dec 31, 2023 | 1.18M | -664.00K | -36.09% |
Dec 31, 2022 | 1.84M | 583.00K | 46.38% |
Dec 31, 2021 | 1.26M | 397.00K | 46.16% |
Dec 31, 2020 | 860.00K | 440.00K | 104.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TIVC News
- 3 days ago - Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers - Business Wire
- 8 days ago - Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025 - Business Wire
- 9 days ago - Tivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Tivic Reports Second Quarter 2025 Financial Results - Business Wire
- 16 days ago - Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast - Business Wire
- 6 weeks ago - Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO - Business Wire
- 2 months ago - Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device - Business Wire
- 2 months ago - Tivic Health Announces 2025 Annual Meeting of Stockholders - Business Wire